Amedisys, Inc. (AMED) Misses Q2 EPS by 4c; Guides FY13
Tweet Send to a Friend
Amedisys, Inc. (NASDAQ: AMED) reported Q2 EPS of $0.06, $0.04 worse than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
